Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).

Bielinski SJ, St Sauver JL, Olson JE, Larson NB, Black JL, Scherer SE, Bernard ME, Boerwinkle E, Borah BJ, Caraballo PJ, Curry TB, Doddapaneni H, Formea CM, Freimuth RR, Gibbs RA, Giri J, Hathcock MA, Hu J, Jacobson DJ, Jones LA, Kalla S, Koep TH, Korchina V, Kovar CL, Lee S, Liu H, Matey ET, McGree ME, McAllister TM, Moyer AM, Muzny DM, Nicholson WT, Oyen LJ, Qin X, Raj R, Roger VL, Rohrer Vitek CR, Ross JL, Sharp RR, Takahashi PY, Venner E, Walker K, Wang L, Wang Q, Wright JA, Wu TJ, Wang L, Weinshilboum RM.

Int J Epidemiol. 2019 Aug 4. pii: dyz123. doi: 10.1093/ije/dyz123. [Epub ahead of print] No abstract available.

PMID:
31378813
2.

Mutation responsible for congenital photosensitivity and hyperbilirubinemia in Southdown sheep.

Posbergh CJ, Kalla SE, Sutter NB, Tennant BC, Huson HJ.

Am J Vet Res. 2018 May;79(5):538-545. doi: 10.2460/ajvr.79.5.538.

PMID:
29688779
3.

Correction: ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones.

Kawabe H, Mitkovski M, Kaeser PS, Hirrlinger J, Opazo F, Nestvogel D, Kalla S, Fejtova A, Verrier SE, Bungers SR, Cooper BH, Varoqueaux F, Wang Y, Nehring RB, Gundelfinger ED, Rosenmund C, Rizzoli SO, Südhof TC, Rhee JS, Brose N.

J Cell Biol. 2017 Apr 3;216(4):1205. doi: 10.1083/jcb.20160608603092017c. Epub 2017 Mar 13. No abstract available.

4.

ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones.

Kawabe H, Mitkovski M, Kaeser PS, Hirrlinger J, Opazo F, Nestvogel D, Kalla S, Fejtova A, Verrier SE, Bungers SR, Cooper BH, Varoqueaux F, Wang Y, Nehring RB, Gundelfinger ED, Rosenmund C, Rizzoli SO, Südhof TC, Rhee JS, Brose N.

J Cell Biol. 2017 Apr 3;216(4):1143-1161. doi: 10.1083/jcb.201606086. Epub 2017 Mar 6. Erratum in: J Cell Biol. 2017 Apr 3;216(4):1205.

5.

Skeletal variation in Tennessee Walking Horses maps to the LCORL/NCAPG gene region.

Staiger EA, Al Abri MA, Pflug KM, Kalla SE, Ainsworth DM, Miller D, Raudsepp T, Sutter NB, Brooks SA.

Physiol Genomics. 2016 May;48(5):325-35. doi: 10.1152/physiolgenomics.00100.2015. Epub 2016 Mar 1.

PMID:
26931356
6.

Complex disease and phenotype mapping in the domestic dog.

Hayward JJ, Castelhano MG, Oliveira KC, Corey E, Balkman C, Baxter TL, Casal ML, Center SA, Fang M, Garrison SJ, Kalla SE, Korniliev P, Kotlikoff MI, Moise NS, Shannon LM, Simpson KW, Sutter NB, Todhunter RJ, Boyko AR.

Nat Commun. 2016 Jan 22;7:10460. doi: 10.1038/ncomms10460.

7.

Pubic symphysis diastasis after an uncomplicated vaginal delivery: A case report.

Saeed F, Trathen K, Want A, Kucheria R, Kalla S.

J Obstet Gynaecol. 2015;35(7):746-7. doi: 10.3109/01443615.2014.992873. Epub 2014 Dec 29. No abstract available.

PMID:
25546521
8.

The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse.

Chen Z, Cooper B, Kalla S, Varoqueaux F, Young SM Jr.

J Neurosci. 2013 May 8;33(19):8336-51. doi: 10.1523/JNEUROSCI.5128-12.2013.

9.

Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses.

Cooper B, Hemmerlein M, Ammermüller J, Imig C, Reim K, Lipstein N, Kalla S, Kawabe H, Brose N, Brandstätter JH, Varoqueaux F.

J Neurosci. 2012 Jun 6;32(23):8040-52. doi: 10.1523/JNEUROSCI.4240-11.2012.

10.

Kin discrimination and possible cryptic species in the social amoeba Polysphondylium violaceum.

Kalla SE, Queller DC, Lasagni A, Strassmann JE.

BMC Evol Biol. 2011 Jan 27;11:31. doi: 10.1186/1471-2148-11-31.

12.

Molecular dynamics of a presynaptic active zone protein studied in Munc13-1-enhanced yellow fluorescent protein knock-in mutant mice.

Kalla S, Stern M, Basu J, Varoqueaux F, Reim K, Rosenmund C, Ziv NE, Brose N.

J Neurosci. 2006 Dec 13;26(50):13054-66.

13.

Social evolution: kin preference in a social microbe.

Mehdiabadi NJ, Jack CN, Farnham TT, Platt TG, Kalla SE, Shaulsky G, Queller DC, Strassmann JE.

Nature. 2006 Aug 24;442(7105):881-2.

PMID:
16929288
14.

NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP.

Yaroslavskiy BB, Zhang Y, Kalla SE, García Palacios V, Sharrow AC, Li Y, Zaidi M, Wu C, Blair HC.

J Cell Sci. 2005 Dec 1;118(Pt 23):5479-87. Epub 2005 Nov 15.

15.

Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero.

Frattini A, Blair HC, Sacco MG, Cerisoli F, Faggioli F, Catò EM, Pangrazio A, Musio A, Rucci F, Sobacchi C, Sharrow AC, Kalla SE, Bruzzone MG, Colombo R, Magli MC, Vezzoni P, Villa A.

Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14629-34. Epub 2005 Sep 29.

16.

Post-partum aortic dissection.

Mukherjee S, Kalla S, Kumar A.

J Obstet Gynaecol. 2005 May;25(4):388-90. No abstract available.

PMID:
16091330
17.

Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 Cells by estrogen and phytoestrogens.

García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE, Blair HC.

J Biol Chem. 2005 Apr 8;280(14):13720-7. Epub 2005 Jan 11.

18.

A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

Louvet C, André T, Gamelin E, Garcia ML, Saavedra A, Lenaers G, de Gramont A, Méry-Mignard D, Kalla S.

Bull Cancer. 2004 Dec;91(12):279-84.

19.

In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.

Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garćia-Palacios V, Oakley JI, Orchard PJ.

J Bone Miner Res. 2004 Aug;19(8):1329-38. Epub 2004 Apr 5.

20.

Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.

Yaroslavskiy BB, Li Y, Ferguson DJ, Kalla SE, Oakley JI, Blair HC.

J Cell Biochem. 2004 Apr 1;91(5):962-72.

PMID:
15034931
21.

Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.

Cao L, Bu R, Oakley JI, Kalla SE, Blair HC.

J Cell Biochem. 2003 May 1;89(1):152-64.

PMID:
12682916
22.

Single-agent gemcitabine is active in previously treated metastatic breast cancer.

Spielmann M, Llombart-Cussac A, Kalla S, Espié M, Namer M, Ferrero JM, Diéras V, Fumoleau P, Cuvier C, Perrocheau G, Ponzio A, Kayitalire L, Pouillart P.

Oncology. 2001;60(4):303-7.

PMID:
11408796
23.

On the low order approximation of radiation fields generated by some hollow-cylindrical ion beams accelerated to produce exoergic nuclear reactions

Timus DM, Bradley DA, Timus BD, Kalla SL, Srivastava HM, Finantu EG, Mateescu EN.

Appl Radiat Isot. 2000 Oct;53(4-5):953-61.

PMID:
11003547
24.

Energy behaviour of neutrons generated by Witch-type distributed axi-symmetrical deuteron beams accelerated onto plane tritium targets

Timus DM, Bradley DA, Timus BD, Kalla SL, Srivastava HM.

Appl Radiat Isot. 2000 Oct;53(4-5):793-9.

PMID:
11003522
25.

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: an investigator-originated compassionate-use experience.

Faivre S, Kalla S, Cvitkovic E, Bourdon O, Hauteville D, Dourte LM, Bensmaïne MA, Itzhaki M, Marty M, Extra JM.

Ann Oncol. 1999 Sep;10(9):1125-8.

PMID:
10572615
26.

Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.

Wasserman E, Cuvier C, Lokiec F, Goldwasser F, Kalla S, Méry-Mignard D, Ouldkaci M, Besmaine A, Dupont-André G, Mahjoubi M, Marty M, Misset JL, Cvitkovic E.

J Clin Oncol. 1999 Jun;17(6):1751-9.

PMID:
10561212
27.

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer.

Misset JL, Dieras V, Gruia G, Bourgeois H, Cvitkovic E, Kalla S, Bozec L, Beuzeboc P, Jasmin C, Aussel JP, Riva A, Azli N, Pouillart P.

Ann Oncol. 1999 May;10(5):553-60.

PMID:
10416005
28.

alpha-thalassemia in the United Arab Emirates.

El-Kalla S, Baysal E.

Acta Haematol. 1998;100(1):49-53.

PMID:
9691147
29.

Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates.

el-Kalla S, Baysal E.

Pediatr Hematol Oncol. 1998 May-Jun;15(3):237-42.

PMID:
9615321
30.

A novel beta-thalassemia mutation [codon 45(-T)] in a Pakistani family.

el-Kalla S, Mathews AR.

Hemoglobin. 1997 Nov;21(6):499-503. No abstract available.

PMID:
9415845
31.

Docetaxel in combination with doxorubicin or vinorelbine.

Diéras V, Fumoleau P, Kalla S, Misset JL, Azli N, Pouillart P.

Eur J Cancer. 1997 Aug;33 Suppl 7:S20-2. Review.

PMID:
9486099
32.

Hb D-Punjab in the United Arab Emirates.

el-Kalla S, Mathews AR.

Hemoglobin. 1997 Jul;21(4):369-75. No abstract available.

PMID:
9255615
33.

A significant beta-thalassemia heterogeneity in the United Arab Emirates.

el-Kalla S, Mathews AR.

Hemoglobin. 1997 May;21(3):237-47.

PMID:
9140720
34.

A comparative study of the awareness and attitude of HIV / AIDS among students living in India and migrants to the United States.

Chakraborty J, Purohit A, Shah S, Kalla S, Purohit S.

AIDS Asia. 1996 Sep-Oct;3(5):16-8.

PMID:
12346520
35.

Relation between perfusion defects on stress technetium-99m sestamibi SPECT scintigraphy and the location of a subsequent acute myocardial infarction.

Miller GL, Herman SD, Heller GV, Kalla S, Levin WA, Stillwell KM, Travin MI.

Am J Cardiol. 1996 Jul 1;78(1):26-30.

PMID:
8712113
36.

A comparative study of the awareness and attitude of HIV/AIDS among students living in India and migrants to the United States.

Chakraborty J, Purohit A, Shah S, Kalla S.

J Assoc Physicians India. 1996 Apr;44(4):237-9.

PMID:
9251391
37.

A novel frameshift mutation causing beta-thalassemia in a Sikh.

el-Kalla S, Mathews AR.

Hemoglobin. 1995 May-Jul;19(3-4):183-9.

PMID:
7558874
38.

Analysis of beta-thalassemia mutations in the United Arab Emirates provides evidence for recurrent origin of the IVSI nt 5 (G-C) mutation.

De Leo R, Deidda G, Novelletto A, el-Kalla S, Mathews AR, Felicetti L.

Hum Mutat. 1995;5(4):327-8.

PMID:
7627187
39.

Cord blood IgE levels in the United Arab Emirates.

Alawar B, el Kalla S, Björkstén B.

Pediatr Allergy Immunol. 1994 Feb;5(1):59-61.

PMID:
8173642
40.

Molecular characterization of beta-thalassemia in the United Arab Emirates.

el-Kalla S, Mathews AR.

Hemoglobin. 1993 Aug;17(4):355-62.

PMID:
8226095
41.

Neonatal congenital factor X deficiency.

el Kalla S, Menon NS.

Am J Pediatr Hematol Oncol. 1993 Feb;15(1):135. No abstract available.

PMID:
8507249
42.

del(18p) syndrome with complex tetralogy of Fallot in an infant with 45,X,t(Y;18)(q12;q11.2).

el Kalla S, Mathews AR, Menon NS.

Am J Med Genet. 1992 Mar 1;42(5):665-6.

PMID:
1632434
43.

Neonatal congenital Factor X deficiency.

el Kalla S, Menon NS.

Pediatr Hematol Oncol. 1991 Oct-Dec;8(4):347-54.

PMID:
1782113
44.

Posterior mediastinal teratoma with abdominal extension.

el Kalla S, Abdul-Hameed M, al Ashbal A, Menon N.

Thorax. 1990 Oct;45(10):773-4.

45.

Down syndrome in Dubai.

el-Kalla S, Mathews AR.

Indian J Pediatr. 1990 Mar-Apr;57(2):275-6. No abstract available.

PMID:
2147171
46.

Mebendazole poisoning in infancy.

el Kalla S, Menon NS.

Ann Trop Paediatr. 1990;10(3):313-4.

PMID:
1703751
47.
48.
49.

In vitro deletions in the partition locus of plasmid pSC101.

Kalla SR, Gustafsson P.

J Bacteriol. 1984 Oct;160(1):434-7.

50.

Erythrocyte glutathione level in relation to haemoglobin type in Rajasthan desert sheep.

Kalla SD, Ghosh PK.

Aust J Biol Sci. 1973 Oct;26(5):1221-3. No abstract available.

PMID:
4797164

Supplemental Content

Support Center